HMGB1 and cancer: Similarly, it has been verified that CAFs exhibit elevated levels of pro-inflammatory factors and can secrete signaling molecules (e.g., IL-8 and HMGB1) that activate the NF-κB pathway in neighboring cancer cells [137–139].